The role of imaging in diagnosing neuromyelitis optica spectrum disorder

Early identification of neuromyelitis optica allows aggressive acute and prophylactic relapse management aimed at preventing disability. Since the discovery of pathogenic aquaporin-4 antibodies the neuromyelitis optica spectrum has widened significantly: brain lesions no longer preclude the diagnosi...

Full description

Bibliographic Details
Main Authors: Matthews, L, Palace, J
Format: Journal article
Language:English
Published: Elsevier 2014
_version_ 1797068743893843968
author Matthews, L
Palace, J
author_facet Matthews, L
Palace, J
author_sort Matthews, L
collection OXFORD
description Early identification of neuromyelitis optica allows aggressive acute and prophylactic relapse management aimed at preventing disability. Since the discovery of pathogenic aquaporin-4 antibodies the neuromyelitis optica spectrum has widened significantly: brain lesions no longer preclude the diagnosis and there are reports of symptoms of cerebral origin presenting as the first manifestation of the condition, prior to optic nerve or spinal cord disease. Defining antibody negative neuromyelitis optica, and distinguishing it from other inflammatory disorders such as multiple sclerosis can therefore be a challenge. In this review we discuss the role of conventional imaging in the diagnosis of neuromyelitis optica, and the scope of quantitative MRI modalities to identify more specific pathophysiological features to aid in the differentiation from other conditions and assess treatment response. © 2013 Elsevier B.V. All rights reserved.
first_indexed 2024-03-06T22:14:31Z
format Journal article
id oxford-uuid:52f1ecc2-31b9-4240-aadc-f1da94be703f
institution University of Oxford
language English
last_indexed 2024-03-06T22:14:31Z
publishDate 2014
publisher Elsevier
record_format dspace
spelling oxford-uuid:52f1ecc2-31b9-4240-aadc-f1da94be703f2022-03-26T16:28:33ZThe role of imaging in diagnosing neuromyelitis optica spectrum disorderJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:52f1ecc2-31b9-4240-aadc-f1da94be703fEnglishSymplectic Elements at OxfordElsevier2014Matthews, LPalace, JEarly identification of neuromyelitis optica allows aggressive acute and prophylactic relapse management aimed at preventing disability. Since the discovery of pathogenic aquaporin-4 antibodies the neuromyelitis optica spectrum has widened significantly: brain lesions no longer preclude the diagnosis and there are reports of symptoms of cerebral origin presenting as the first manifestation of the condition, prior to optic nerve or spinal cord disease. Defining antibody negative neuromyelitis optica, and distinguishing it from other inflammatory disorders such as multiple sclerosis can therefore be a challenge. In this review we discuss the role of conventional imaging in the diagnosis of neuromyelitis optica, and the scope of quantitative MRI modalities to identify more specific pathophysiological features to aid in the differentiation from other conditions and assess treatment response. © 2013 Elsevier B.V. All rights reserved.
spellingShingle Matthews, L
Palace, J
The role of imaging in diagnosing neuromyelitis optica spectrum disorder
title The role of imaging in diagnosing neuromyelitis optica spectrum disorder
title_full The role of imaging in diagnosing neuromyelitis optica spectrum disorder
title_fullStr The role of imaging in diagnosing neuromyelitis optica spectrum disorder
title_full_unstemmed The role of imaging in diagnosing neuromyelitis optica spectrum disorder
title_short The role of imaging in diagnosing neuromyelitis optica spectrum disorder
title_sort role of imaging in diagnosing neuromyelitis optica spectrum disorder
work_keys_str_mv AT matthewsl theroleofimagingindiagnosingneuromyelitisopticaspectrumdisorder
AT palacej theroleofimagingindiagnosingneuromyelitisopticaspectrumdisorder
AT matthewsl roleofimagingindiagnosingneuromyelitisopticaspectrumdisorder
AT palacej roleofimagingindiagnosingneuromyelitisopticaspectrumdisorder